Calamos Wealth Management LLC Buys Shares of 4,698 CVS Health Corporation $CVS

Calamos Wealth Management LLC bought a new stake in shares of CVS Health Corporation (NYSE:CVS) in the 2nd quarter, Holdings Channel reports. The institutional investor bought 4,698 shares of the pharmacy operator’s stock, valued at approximately $324,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of CVS Health by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator’s stock valued at $8,017,223,000 after buying an additional 969,027 shares in the last quarter. Dodge & Cox increased its position in shares of CVS Health by 4.8% in the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock valued at $4,976,856,000 after buying an additional 3,353,223 shares in the last quarter. Invesco Ltd. increased its position in shares of CVS Health by 13.2% in the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator’s stock valued at $1,383,039,000 after buying an additional 2,375,764 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of CVS Health by 14.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,309,289 shares of the pharmacy operator’s stock valued at $1,037,205,000 after buying an additional 1,942,886 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of CVS Health by 5.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator’s stock valued at $924,643,000 after buying an additional 728,924 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent analyst reports. Sanford C. Bernstein upped their price objective on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. The Goldman Sachs Group began coverage on shares of CVS Health in a research note on Tuesday, October 14th. They issued a “buy” rating and a $91.00 target price for the company. Wells Fargo & Company upped their target price on shares of CVS Health from $84.00 to $103.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CVS Health in a research note on Tuesday, October 14th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $78.00 target price on shares of CVS Health in a research note on Tuesday, August 26th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $82.57.

CVS Health Trading Up 1.6%

CVS Health stock opened at $82.64 on Monday. The firm has a 50-day moving average of $74.00 and a 200-day moving average of $68.12. CVS Health Corporation has a one year low of $43.56 and a one year high of $82.88. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The company has a market cap of $104.81 billion, a price-to-earnings ratio of 23.08, a P/E/G ratio of 0.91 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. During the same period last year, the business posted $1.83 EPS. CVS Health’s revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.2%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 74.30%.

Insider Transactions at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.22% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.